Kyle Swanson, MD
Sports Medicine · Carson City, NVNPI 1538123492
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (47.5%), education and travel and lodging — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by Stryker at 30.2% of the total. Reporting peaked in 2022 at $3,818 and has fallen 84.0% since, to $610 in 2025.
Across 98 payments — averaging $99.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$3K
- Arthrex$2K
- Sequoia Surgical, Inc.$2K
- Cornerstone Medical Associates, Inc.$1K
- Johnson & Johnson$594
- Vericel Corporation$177
- plus $600 from 12 others
What the payments were for
- Travel & lodging$1,65217%
- Food & beverage$4,65548%
- Education$3,49136%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 47 | $2,961 |
| Arthrex | 18 | $2,301 |
| Sequoia Surgical, Inc. | 2 | $2,161 |
| Cornerstone Medical Associates, Inc. | 1 | $1,004 |
| Johnson & Johnson | 13 | $594 |
| Vericel Corporation | 2 | $177 |
| Goode Surgical Inc | 3 | $165 |
| Evolution Surgical, Inc | 1 | $103 |
| Smith+Nephew | 1 | $68 |
| Medical Device Business Services, Inc. | 2 | $62 |
| Biocomposites Inc | 1 | $43 |
| Medtronic | 1 | $38 |
| Vertex | 1 | $28 |
| Moximed, Inc | 1 | $22 |
| Solventum Corporation | 1 | $22 |
| Avanos Medical | 1 | $20 |
| Bioventus LLC | 1 | $16 |
| Merck | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MAKO$749
- PRIME SERIES$521
- TRAUMA$153
- MONOVISC$124
- MACI$105
How this compares
$9,798 in reported general payments places this provider in the 70th percentile of 49 sports medicine providers in Nevada.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 61 | $370 |
| Celecoxib | 15 | $358 |
| Ondansetron Hcl | 42 | $250 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 23 | $126 |
| Tramadol Hcl | 20 | $95 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in Carson City
- Brian GilmerReno$204K
- Chad HansonLas Vegas$158K
- Angelina VeraLas Vegas$55K
- Daniel CurtisReno$42K
- Alex LencioniReno$41K
- Andrew HausNellis Afb$37K
- Anthony BrattonLas Vegas$33K
- Troy ShieldsReno$26K
- Kyle HancockLas Vegas$20K
- Richard WinderLas Vegas$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.